488 related articles for article (PubMed ID: 20380535)
1. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
2. Validating a new generation filter system for visualizing 5-ALA-induced PpIX fluorescence in malignant glioma surgery: a proof of principle study.
Suero Molina E; Stögbauer L; Jeibmann A; Warneke N; Stummer W
Acta Neurochir (Wien); 2020 Apr; 162(4):785-793. PubMed ID: 32034493
[TBL] [Abstract][Full Text] [Related]
3. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis.
Yagi R; Kawabata S; Ikeda N; Nonoguchi N; Furuse M; Katayama Y; Kajimoto Y; Kuroiwa T
World J Surg Oncol; 2017 Sep; 15(1):179. PubMed ID: 28962578
[TBL] [Abstract][Full Text] [Related]
5. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
6. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
Colditz MJ; Jeffree RL
J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
[TBL] [Abstract][Full Text] [Related]
7. Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection.
Roberts DW; Olson JD; Evans LT; Kolste KK; Kanick SC; Fan X; Bravo JJ; Wilson BC; Leblond F; Marois M; Paulsen KD
J Neurosurg; 2018 Jun; 128(6):1690-1697. PubMed ID: 28777025
[TBL] [Abstract][Full Text] [Related]
8. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
9. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
10. Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma.
Belykh E; Miller EJ; Hu D; Martirosyan NL; Woolf EC; Scheck AC; Byvaltsev VA; Nakaji P; Nelson LY; Seibel EJ; Preul MC
World Neurosurg; 2018 May; 113():e51-e69. PubMed ID: 29408716
[TBL] [Abstract][Full Text] [Related]
11. δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy.
Valdés PA; Kim A; Brantsch M; Niu C; Moses ZB; Tosteson TD; Wilson BC; Paulsen KD; Roberts DW; Harris BT
Neuro Oncol; 2011 Aug; 13(8):846-56. PubMed ID: 21798847
[TBL] [Abstract][Full Text] [Related]
12. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
14. Estimation of brain deformation for volumetric image updating in protoporphyrin IX fluorescence-guided resection.
Valdés PA; Fan X; Ji S; Harris BT; Paulsen KD; Roberts DW
Stereotact Funct Neurosurg; 2010; 88(1):1-10. PubMed ID: 19907205
[TBL] [Abstract][Full Text] [Related]
15. Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study. Clinical article.
Stummer W; Tonn JC; Mehdorn HM; Nestler U; Franz K; Goetz C; Bink A; Pichlmeier U;
J Neurosurg; 2011 Mar; 114(3):613-23. PubMed ID: 20397896
[TBL] [Abstract][Full Text] [Related]
16. 5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancement.
Widhalm G; Kiesel B; Woehrer A; Traub-Weidinger T; Preusser M; Marosi C; Prayer D; Hainfellner JA; Knosp E; Wolfsberger S
PLoS One; 2013; 8(10):e76988. PubMed ID: 24204718
[TBL] [Abstract][Full Text] [Related]
17. Dual-labeling with 5-aminolevulinic acid and fluorescein for fluorescence-guided resection of high-grade gliomas: technical note.
Suero Molina E; Wölfer J; Ewelt C; Ehrhardt A; Brokinkel B; Stummer W
J Neurosurg; 2018 Feb; 128(2):399-405. PubMed ID: 28338432
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience.
Chan DTM; Yi-Pin Sonia H; Poon WS
Asian J Surg; 2018 Sep; 41(5):467-472. PubMed ID: 28844780
[TBL] [Abstract][Full Text] [Related]
19. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
20. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.
Valdés PA; Leblond F; Kim A; Harris BT; Wilson BC; Fan X; Tosteson TD; Hartov A; Ji S; Erkmen K; Simmons NE; Paulsen KD; Roberts DW
J Neurosurg; 2011 Jul; 115(1):11-7. PubMed ID: 21438658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
